Number of employees
30-49
P.R.I.S.M.A. has recently completed enrolment in a double-blind, placebo controlled, pulmonary arterial hypertension study. P.R.I.S.M.A.-staff has extensive experience in PAH and to date has completed 8 studies in this orphan drug indication.
ResearchPoint Global is a full-service CRO with 22 global offices and clinical coverage in over 60 countries.